Bank of AmericaGrowth NoteSnowball3 Years
Traded Nov 2026 · Matures Nov 2029
Timeline
Last updated on Nov 17, 2026
Snowball Growth Note w/ Memorizer - Earn 30.25% in Year-1 or up to 90.75% in Year-3
Abbott Laboratories
ABT
Develops medical devices, diagnostic products, nutritional products, and branded generic medicines for healthcare markets worldwide
Market Cap
$196bn
3-Yr CAGR
5%
3-Yr Max DD
-36%
Pfizer Inc
PFE
Develops and manufactures prescription medicines and vaccines across oncology, immunology, infectious diseases, and other therapeutic areas
Market Cap
$170bn
3-Yr CAGR
3%
3-Yr Max DD
-21%
Eli Lilly & Co.
LLY
Discovers, develops, and manufactures innovative medicines for diabetes, obesity, oncology, immunology, and neuroscience
Market Cap
$1,220bn
3-Yr CAGR
38%
3-Yr Max DD
-23%
CAGR: Compound Annual Growth Rate · DD: Maximum Drawdown
Note is called in Year-1
30.25%
Note is called in Year-2
60.5%
Note is called in Year-3
90.75%
If the worst stock falls past the barrier
You can lose some or all of what you invested
Snowball Call Premium: Starting at 30.25% after Year 1, the call premium increases by 2.52% each month until the note is called or reaches maturity.
Memorizer Autocall: From Year 1, each underlier (ABT / PFE / LLY) only needs to reach 100% of its initial level on a monthly observation date once. The note is called when all three underliers have met this condition, paying full principal plus the applicable call premium.
Maturity Protection: If the note goes till maturity, investors receive full principal plus 90.75% if all three underliers have reached their initial levels on an observation date. Otherwise, principal is returned if the worst-performing underlier is not down more than 40% at maturity; below the 60% barrier, losses are 1:1 with the worst-performing underlier.